68 related articles for article (PubMed ID: 15585481)
1. Prediction of survival and therapy outcome with 11C-tyrosine PET in patients with laryngeal carcinoma.
de Boer JR; Pruim J; Albers FW; Burlage F; Vaalburg W; van der Laan BF
J Nucl Med; 2004 Dec; 45(12):2052-7. PubMed ID: 15585481
[TBL] [Abstract][Full Text] [Related]
2. L-1-11C-tyrosine PET in patients with laryngeal carcinomas: comparison of standardized uptake value and protein synthesis rate.
de Boer JR; Pruim J; van der Laan BF; Que TH; Willemsen AT; Albers FW; Vaalburg W
J Nucl Med; 2003 Mar; 44(3):341-6. PubMed ID: 12620998
[TBL] [Abstract][Full Text] [Related]
3. Carbon-11 tyrosine PET for visualization and protein synthesis rate assessment of laryngeal and hypopharyngeal carcinomas.
de Boer JR; van der Laan BF; Pruim J; Que TH; Burlage F; Krikke A; Willemsen AT; Tiebosch AT; Albers FW; Vaalburg W
Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1182-7. PubMed ID: 12192563
[TBL] [Abstract][Full Text] [Related]
4. Therapy evaluation of laryngeal carcinomas by tyrosine-pet.
De Boer JR; Pruim J; Burlage F; Krikke A; Tiebosch AT; Albers FW; Vaalburg W; Van Der Laan BF
Head Neck; 2003 Aug; 25(8):634-44. PubMed ID: 12884346
[TBL] [Abstract][Full Text] [Related]
5. 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx.
Roh JL; Pae KH; Choi SH; Kim JS; Lee S; Kim SB; Nam SY; Kim SY
Eur J Surg Oncol; 2007 Aug; 33(6):790-5. PubMed ID: 17306956
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET prediction of head and neck squamous cell cancer outcomes.
Schwartz DL; Rajendran J; Yueh B; Coltrera MD; Leblanc M; Eary J; Krohn K
Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1361-7. PubMed ID: 15611393
[TBL] [Abstract][Full Text] [Related]
7. Carbon-11-methionine uptake in squamous cell head and neck cancer.
Lindholm P; Leskinen S; Lapela M
J Nucl Med; 1998 Aug; 39(8):1393-7. PubMed ID: 9708515
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma.
Vernon MR; Maheshwari M; Schultz CJ; Michel MA; Wong SJ; Campbell BH; Massey BL; Wilson JF; Wang D
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):678-84. PubMed ID: 18262086
[TBL] [Abstract][Full Text] [Related]
9. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y
Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002
[TBL] [Abstract][Full Text] [Related]
10. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
11. Laryngeal or hypopharyngeal squamous cell carcinoma: can follow-up CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone?
Hermans R; Pameijer FA; Mancuso AA; Parsons JT; Mendenhall WM
Radiology; 2000 Mar; 214(3):683-7. PubMed ID: 10715030
[TBL] [Abstract][Full Text] [Related]
12. Visualisation and assessment of the protein synthesis rate of lung cancer using carbon-11 tyrosine and positron emission tomography.
Pieterman R; Willemsen A; Appel M; Pruim J; Koëter G; Vaalburg W; Groen H
Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):243-7. PubMed ID: 11926387
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
Guo H; Zhu H; Xi Y; Zhang B; Li L; Huang Y; Zhang J; Fu Z; Yang G; Yuan S; Yu J
J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and [11C]methionine.
Lindholm P; Leskinen-Kallio S; Grénman R; Lehikoinen P; Någren K; Teräs M; Ruotsalainen U; Joensuu H
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):787-94. PubMed ID: 7790265
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
Choi JY; Jang HJ; Shim YM; Kim K; Lee KS; Lee KH; Choi Y; Choe YS; Kim BT
J Nucl Med; 2004 Nov; 45(11):1843-50. PubMed ID: 15534053
[TBL] [Abstract][Full Text] [Related]
16. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
17. L-[1-11C]-tyrosine PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma and skin cancer.
van Ginkel RJ; Kole AC; Nieweg OE; Molenaar WM; Pruim J; Koops HS; Vaalburg W; Hoekstra HJ
J Nucl Med; 1999 Feb; 40(2):262-7. PubMed ID: 10025833
[TBL] [Abstract][Full Text] [Related]
18. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.
Minn H; Lapela M; Klemi PJ; Grénman R; Leskinen S; Lindholm P; Bergman J; Eronen E; Haaparanta M; Joensuu H
J Nucl Med; 1997 Dec; 38(12):1907-11. PubMed ID: 9430467
[TBL] [Abstract][Full Text] [Related]
19. Laryngeal edema after radiotherapy in patients with squamous cell carcinomas of the larynx and hypopharynx.
Bae JS; Roh JL; Lee SW; Kim SB; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
Oral Oncol; 2012 Sep; 48(9):853-8. PubMed ID: 22436885
[TBL] [Abstract][Full Text] [Related]
20. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?
Jones AS; Fish B; Fenton JE; Husband DJ
Head Neck; 2004 Feb; 26(2):127-35. PubMed ID: 14762881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
